Particle.news
Cognitive Decline Lecanemab Treatment Options Symptoms Biomarkers Mild Cognitive Impairment Risk Factors Donanemab Treatment Methods Cognitive Function Restoration Early Diagnosis Sleep Disorders Model Development Therapies Trontinemab Occupational Health Differential Diagnosis Drug Development Prediction Models Medications Prevention Strategies Early Stage Alzheimer's Treatment Risk Reduction Patient Care Diagnosis Clinical Trials Inhibition Dementia Prevention Drug Impact Cognitive Decline Prediction Intranasal Insulin Disease Progression Vaccine Impact Monoclonal Antibodies Diagnostic Tests
Misdiagnoses of early symptoms alongside specialist shortages have prolonged dementia diagnosis times, prompting calls for national standards with sustained funding.
